Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Granite Construction
GVA
$5.4B
| $940K | ﹤0.01% |
23,624
-1,754
| -7% | -$67.1K |
|
2277
Peoples Bancorp
PEBO
$1.5B
| $938K | ﹤0.01% |
35,317
+10,903
| +45% | +$284K |
|
|
VGR
2278
DELISTED
Vector Group Ltd.
VGR
| $937K | ﹤0.01% |
73,161
-41,593
| -36% | -$513K |
|
2279
ProFrac Holding
ACDC
$814M
| $936K | ﹤0.01% |
83,890
+71,761
| +592% | +$850K |
|
2280
Rush Enterprises Class B
RUSHB
$6.16B
| $935K | ﹤0.01% |
20,607
-1,169
| -5% | -$47.3K |
|
|
STR
2281
DELISTED
Sitio Royalties
STR
| $933K | ﹤0.01% |
35,521
-1,884
| -5% | -$48.2K |
|
2282
Icahn Enterprises
IEP
$5.01B
| $929K | ﹤0.01% |
32,002
+11,644
| +57% | +$424K |
|
2283
CorVel
CRVL
$3.19B
| $929K | ﹤0.01% |
14,397
+1,083
| +8% | +$72.5K |
|
2284
Covenant Logistics
CVLG
$900M
| $928K | ﹤0.01% |
42,354
-5,346
| -11% | -$103K |
|
2285
Methanex
MEOH
$4.02B
| $927K | ﹤0.01% |
22,396
+12,896
| +136% | +$557K |
|
|
EQC
2286
DELISTED
Equity Commonwealth
EQC
| $926K | ﹤0.01% |
45,698
-66,809
| -59% | -$1.38M |
|
2287
Standex International
SXI
$3.95B
| $926K | ﹤0.01% |
6,543
+422
| +7% | +$55.7K |
|
2288
Beazer Homes USA
BZH
$931M
| $923K | ﹤0.01% |
32,629
-11,150
| -25% | -$227K |
|
2289
Dyne Therapeutics
DYN
$4.89B
| $922K | ﹤0.01% |
81,971
+49,883
| +155% | +$588K |
|
|
NXGN
2290
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $919K | ﹤0.01% |
56,642
-126
| -0.2% | -$2.09K |
|
|
OPLN
2291
Openlane
OPLN
$4.69B
| $914K | ﹤0.01% |
60,082
+3,971
| +7% | +$57.9K |
|
2292
Virtus Investment Partners
VRTS
$1.08B
| $911K | ﹤0.01% |
4,612
-1,509
| -25% | -$285K |
|
2293
RadNet
RDNT
$5.27B
| $908K | ﹤0.01% |
27,845
+2,518
| +10% | +$73.2K |
|
2294
Harmonic Inc
HLIT
$1.3B
| $908K | ﹤0.01% |
56,169
+9,318
| +20% | +$150K |
|
2295
World Kinect Corp
WKC
$1.97B
| $906K | ﹤0.01% |
43,811
-413
| -0.9% | -$9.84K |
|
2296
Enerpac Tool Group
EPAC
$1.89B
| $905K | ﹤0.01% |
33,533
-2,173
| -6% | -$55.1K |
|
2297
Fastly Inc
FSLY
$4.07B
| $905K | ﹤0.01% |
57,400
-52,461
| -48% | -$804K |
|
2298
US Physical Therapy
USPH
$1.18B
| $905K | ﹤0.01% |
7,453
+932
| +14% | +$100K |
|
2299
Usana Health Sciences
USNA
$277M
| $904K | ﹤0.01% |
14,343
-299
| -2% | -$19K |
|
2300
PSQ Holdings
PSQH
$14M
| $902K | ﹤0.01% |
5,854
| – | – |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.